Search Results
Apr 20, 2026, 04:00 ET HIKMICRO, World Leader in Smart Thermal Imaging, Marks 10th Anniversary with Launch of Trailblazing AI-Powered SuperScene™ Mode
setting a new benchmark in usability and performance."Our vision from day one was to take thermal imaging solutions from niche applications to the mass market, adding more intelligence and accessibility," says Stefan Li, Overseas General Manager at HIKMICRO. "SuperScene™ Mode marks a new chapter in
More news about: HIKMICRO
Apr 20, 2026, 03:00 ET LG Innotek to Supply Cutting-Edge Automotive Wi-Fi 7 Communication Module to a leading European automotive parts company
Order value of approximately USD 68M with mass production to begin in 2027Offering data transmission speed three times faster, with no speed degradation even with multiple devices connected simultaneouslyChanging perception of car considered as
More news about: LG Innotek
Apr 19, 2026, 19:48 ET SK hynix Begins Mass Production of 192GB SOCAMM2 'Setting a New Standard for AI Server Memory Performance'
- Mass production of 192GB high capacity products designed for the NVIDIA Vera Rubin platform- Maximizes power efficiency by featuring high density DRAM based on the latest 1cnm process- Company to closely collaborate with NVIDIA to solve bottlenecks
More news about: SK hynix Inc.
Apr 19, 2026, 09:58 ET Four Texan Heroes Receive Henry Repeating Arms Tribute
Houston, Texas, including the first public recognition of three Austin Police Department officers for their actions in stopping the perpetrator of a recent mass shooting event in Austin.
More news about: Henry Repeating Arms
Apr 18, 2026, 19:44 ET BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES
theoretical physics. For example, he and his collaborators developed a simplified quantum field theory that helped explain how particles can acquire mass; and developed new theoretical approaches attempting to unify all fundamental forces, including gravity, in a single framework known as heterotic
More news about: Breakthrough Prize
Apr 18, 2026, 07:34 ET Global Sources Hong Kong Shows Phase II Officially Opens, AI Products Go Mainstream as Humanoid Robot Zone Makes Its Debut
sourcing hub is evolving in tandem. John Kao, Vice President of Hong Kong Shows & Overseas Shows at Global Sources, said: "AI is moving from concept to mass production — the wave of technology reshaping products has arrived. The biggest change at this year's show is that AI is no longer confined to a standalone
More news about: Global Sources
Apr 18, 2026, 07:29 ET Three Papers Published Consecutively in Nature Energy: JinkoSolar's Breakthroughs in TOPCon/Perovskite Tandem Technology Receive Authoritative Recognition
and introducing localized contacts on the back side to reduce the polycrystalline silicon layer thickness, parasitic absorption can be reduced, and mass production efficiency is expected to approach 27%.Using a high-efficiency bifacial TOPCon cell with a textured front surface as the bottom cell,
More news about: JinkoSolar
Apr 17, 2026, 16:14 ET Sun Life U.S. receives Top Workplaces award from Milwaukee Journal Sentinel for third consecutive year
practices and affiliated companies in asset management. Group insurance policies are issued by Sun Life Assurance Company of Canada (Wellesley Hills, Mass.), except in New York, where policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, Mich.). For more information visit our
More news about: Sun Life U.S.
Apr 17, 2026, 16:01 ET New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
differentiated brain penetrance and intracranial activity as compared to repotrectinib and taletrectinibCAMBRIDGE, Mass., April 17, 2026 /PRNewswire/ -- Nuvalent,
More news about: Nuvalent, Inc.
Apr 17, 2026, 15:00 ET Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
best-in-class KIF18A inhibitor, in multiple preclinical chromosomally instable cancer modelsLEXINGTON, Mass., April 17, 2026 /PRNewswire/ -- Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel
More news about: Accent Therapeutics
Apr 17, 2026, 15:00 ET Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting
tertiary lymphoid structures may help identify patients most likely to benefit from IMT-009 treatmentWALTHAM, Mass., April 17, 2026 /PRNewswire/ --
More news about: Immunitas Therapeutics, Inc.
Apr 17, 2026, 15:00 ET Nested Therapeutics Reports Initial Encouraging Clinical Activity and Favorable Tolerability of NST-628, a Brain-Penetrant Pan-RAF/MEK Molecular Glue, at AACR 2026
U.S. with no approved targeted therapies following treatment with immune checkpoint inhibitors CAMBRIDGE, Mass., April 17, 2026 /PRNewswire/ -- Nested Therapeutics, a clinical-stage oncology company developing transformative
More news about: Nested Therapeutics Inc.
Apr 17, 2026, 14:12 ET AGIBOT Declares 2026 "Deployment Year One" at APC 2026, Accelerating the Era of Embodied AI Productivity
Building on three years of rapid evolution, from R&D to mass production to commercialization, AGIBOT highlighted a fundamental industry transition: artificial intelligence is moving beyond digital cognition into
More news about: AGIBOT
Apr 17, 2026, 14:03 ET AGIBOT Declares 2026 "Deployment Year One" at APC 2026, Accelerating the Era of Embodied AI Productivity
Building on three years of rapid evolution, from R&D to mass production to commercialization, AGIBOT highlighted a fundamental industry transition: artificial intelligence is moving beyond digital cognition into
More news about: AGIBOT
Apr 17, 2026, 11:00 ET CREATE Medicines to Showcase Multi-immune In Vivo CAR T, CAR NK, and All-RNA RetroT Platform at AACR 2026
leadership in in vivo immune cell engineering across T cells, NK cells, and myeloid cellsCAMBRIDGE, Mass., April 17, 2026 /PRNewswire/ -- CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering
More news about: CREATE Medicines, Inc.
Apr 17, 2026, 10:38 ET DALBAR's 2026 QAIB Report Shows Narrower Investor Gap Amid a Complex and Volatile Market Year
MARLBOROUGH, Mass., April 17, 2026 /PRNewswire/ -- DALBAR has released its 2026 Quantitative Analysis of Investor Behavior (QAIB) Report, revealing that the long‑standing gap between investor returns and market performance
More news about: DALBAR, Inc.
Apr 17, 2026, 09:16 ET GEMI SHAREHOLDER UPDATE: Gemini (GEMI) Post-IPO Meltdown Sparks Securities Class Action as Investors Seek Recovery - Hagens Berman
that the company would shift focus to prediction markets, exit the United Kingdom and Australia, and reduce its workforce by 25%.Mass Executive Exodus: On February 17, 2026, Gemini announced the simultaneous "parting of ways" with its COO (Marshall Beard), CFO (Dan Chen),
More news about: Hagens Berman Sobol Shapiro LLP
Apr 17, 2026, 09:15 ET XPENG to Showcase "Physical AI" Ecosystem at Beijing Auto Show, Outlining Global Vision for Smart Mobility
intelligent driving, robotics, and aerial mobility, alongside the latest technical and product updates. 2026 marks a milestone as Physical AI enters mass production. At the Auto Show, XPENG will showcase the VLA 2.0 intelligent driving system, flagship models, as well as the latest progress in robotics
More news about: XPENG
Apr 17, 2026, 09:00 ET L'Oréal Paris and Ulta Beauty Unveil "Mother & ___" Campaign: A Celebration of the Limitless Worth and Multifaceted Identities of Motherhood
L'Oréal USA, Inc. is a total beauty care brand dedicated to empowering women by offering luxurious and innovative products and services available in the mass market. The brand's signature tagline, "Because I'm Worth It," was born in the United States in 1973 to celebrate the beauty and intrinsic self-worth
More news about: L'Oreal Paris USA
Apr 17, 2026, 09:00 ET Parker Institute for Cancer Immunotherapy Network Shapes the Future Of Immunotherapy with Latest Research at AACR Annual Meeting 2026
Abstract 4084), and tumor mass dormancy in melanoma (
More news about: Parker Institute for Cancer Immunotherapy
Apr 17, 2026, 08:51 ET MONDAY DEADLINE: Berger Montague Advises NuScale Power Corporation (NYSE: SMR) Investors to Inquire About a Securities Fraud Class Action by April 20, 2026
(267)764-4865.About Berger MontagueBerger Montague is one of the nation's preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader
More news about: Berger Montague
Apr 17, 2026, 08:34 ET Red Wheel/Weiser Acquires Watkins Publishing, Uniting Two Historic Leaders in Mind, Body, Spirit Publishing
NEWBURYPORT, Mass. and LONDON, April 17, 2026 /PRNewswire/ -- Red Wheel/Weiser announces the acquisition of the majority of the titles of Watkins Publishing, the flagship imprint of Watkins Media. The transaction brings
More news about: Red Wheel/Weiser
Apr 17, 2026, 08:30 ET Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
subtypesFirst public disclosure of clinical stage Ipsen-partnered STAR program IPN01203 CAMBRIDGE, Mass., April 17, 2026 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering
More news about: Marengo Therapeutics
Apr 17, 2026, 06:00 ET Harbinger Health Presents Multiple Studies at AACR Reinforcing Platform Foundation for RESOLVE™, a New Category for Cancer Detection
provide actionable insight across cancer types and clinical contexts when cancer is suspectedCAMBRIDGE, Mass., April 17, 2026 /PRNewswire/ --
More news about: Harbinger Health
Apr 17, 2026, 03:13 ET 1,000+ Attendees and 100+ CMOs Expected at the 8th Edition of Brand World Summit
evolving faster than ever. Against this backdrop, BWS 2026 will serve as the definitive platform for marketing leaders to navigate the collision of mass media, precision targeting, and Artificial Intelligence.With India emerging at the centre of the brand world, this year, the summit will focus
More news about: ETBrandEquity